Discovery of clinical isolation of drug-resistant Klebsiella pneumoniae with overexpression of OqxB efflux pump as the decisive drug resistance factor

Author:

Tian Ping1234ORCID,Guo Ming-Juan5,Li Qing-Qing1234,Li Xu-Feng1234,Liu Xiao-Qiang1234,Kong Qin-Xiang6,Zhang Hui12,Yang Yi1234,Liu Yan-Yan1234,Yu Liang1234,Li Jia-Bin1234ORCID,Li Ya-Sheng1234ORCID

Affiliation:

1. Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China

2. Anhui Province Key Laboratory of Infectious Diseases, Anhui Medical University, Hefei, China

3. Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China

4. Institute of Bacterial Resistance, Anhui Medical University, Hefei, China

5. Department of Hepatology, The First Affiliated Hospital of Jilin University, Changchun, China

6. Department of Infectious Diseases, Chaohu Hospital of Anhui Medical University, Hefei, China

Abstract

ABSTRACT Background emergence of multidrug-resistant (MDR) bacterial strains is a public health concern that threatens global and regional security. Efflux pump-overexpressing MDR strains from clinical isolates are the best subjects for studying the mechanisms of MDR caused by bacterial efflux pumps. A Klebsiella pneumoniae strain overexpressing the OqxB-only efflux pump was screened from a clinical strain library to explore reverse OqxB-mediated bacterial resistance strategies. We identified non-repetitive clinical isolated K. pneumoniae strains using a matrix-assisted laser desorption/ionization time-of-flight (TOF) mass spectrometry clinical TOF-II (Clin-TOF-II) and susceptibility test screening against levofloxacin and ciprofloxacin. And the polymorphism analysis was conducted using pulsed-field gel electrophoresis. Efflux pump function of resistant strains is obtained by combined drug sensitivity test of phenylalanine-arginine beta-naphthylamide (PaβN, an efflux pump inhibitor) and detection with ethidium bromide as an indicator. The quantitative reverse transcription PCR was performed to assess whether the oqxB gene was overexpressed in K. pneumoniae isolates. Additional analyses assessed whether the oqxB gene was overexpressed in K. pneumoniae isolates and gene knockout and complementation strains were constructed. The binding mode of PaβN with OqxB was determined using molecular docking modeling. Among the clinical quinolone-resistant K. pneumoniae strains, one mediates resistance almost exclusively through the overexpression of the resistance–nodulation–division efflux pump, OqxB. Crystal structure of OqxB has been reported recently by N. Bharatham, P. Bhowmik, M. Aoki, U. Okada et al. (Nat Commun 12:5400, 2021, https://doi.org/10.1038/s41467-021-25679-0 ). The discovery of this strain will contribute to a better understanding of the role of the OqxB transporter in K. pneumoniae and builds on the foundation for addressing the threat posed by quinolone resistance. IMPORTANCE The emergence of antimicrobial resistance is a growing and significant health concern, particularly in the context of K. pneumoniae infections. The upregulation of efflux pump systems is a key factor that contributes to this resistance. Our results indicated that the K. pneumoniae strain GN 172867 exhibited a higher oqxB gene expression compared to the reference strain ATCC 43816. Deletion of oqxB led a decrease in the minimum inhibitory concentration of levofloxacin. Complementation with oqxB rescued antibiotic resistance in the oqxB mutant strain. We demonstrated that the overexpression of the OqxB efflux pump plays an important role in quinolone resistance. The discovery of strain GN 172867 will contribute to a better understanding of the role of the OqxB transporter in K. pneumoniae and promotes further study of antimicrobial resistance.

Funder

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

American Society for Microbiology

Reference36 articles.

1. Fight Against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria

2. World Health Organization. 2019. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics. Available from: http://www.who.int/ medicines/publications/WHOPPL-Short

3. The Science of Antibiotic Discovery

4. Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors

5. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3